Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Adagio Medical Holdings, Inc. ADGM NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
18/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Adagio Medical Holdings, Inc. (ADGM) is a Medical - Devices company in the Healthcare sector, currently trading at $1.43. It has a SharesGrow Score of 17/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Valuation: ADGM trades at a trailing Price-to-Earnings (P/E) of -1.2 (S&P 500 average ~25).

Net income is $25M (loss), growing at -1220.3%/yr. Net profit margin is 0% (thin). Gross margin is -620.1% (-257.1 pp trend).

Balance sheet: total debt is $22M against $12M equity (Debt-to-Equity (D/E) ratio 1.75, leveraged). Current ratio is 2.44 (strong liquidity). Debt-to-assets is 50.3%. Total assets: $43M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 33/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

ADGM SharesGrow Score Overview

24/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ADGM

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
ADGM: -17.2%/yr revenue is, -1220.3%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
ADGM: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
33/100
Balance sheet ADGM: Debt-to-Equity (D/E) ratio 1.75 (leveraged), Current ratio is 2.44 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.625-2.87
Volume82.06K
Avg Volume (30D)98.1K
Market Cap$21.77M
Beta (1Y)0.04
Share Statistics
EPS (TTM)-1.51
Shares Outstanding$16.58M
IPO Date2024-07-23
Employees80
CEOTodd Usen
Financial Highlights & Ratios
Gross Profit$-684K
EBITDA$-21.89M
Net Income$-25.08M
Operating Income$-21.89M
Total Cash$17.11M
Total Debt$21.76M
Net Debt$4.65M
Total Assets$43.25M
Price / Earnings (P/E)-0.9
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS00534B1008

Price Chart

Track all markets on TradingView
ADGM
Adagio Medical Holdings, Inc. ↗  ·  NASDAQ Global Market
Healthcare • Medical - Devices
0.63 52WK RANGE 2.87

People Also View

LPTX
LPTX
Leap Therapeutics, Inc.
$0.77
-3.15%
 ATHA
ATHA
Athira Pharma, Inc.
$6.75
-6.12%
 IRIX
IRIX
IRIDEX Corporation
$1.04
+0.97%
 COCH
COCH
Envoy Medical, Inc.
$0.72
+8.21%
 CTXR
CTXR
Citius Pharmaceuticals, Inc.
$0.86
+3.88%
 VVOS
VVOS
Vivos Therapeutics, Inc.
$1.47
+8.89%
 ALUR
ALUR
Allurion Technologies Inc.
$0.90
+7.12%
 VSEE
VSEE
VSee Health, Inc.
$0.23
-2.37%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message